Atomera Added to Membership of Russell 2000® and 3000® Indexes
LOS GATOS, Calif., June 30, 2020 (GLOBE NEWSWIRE) — Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and intellectual property licensing […]
KVH Launches New Inertial Sensor with Photonic Integrated Chip Technology
MIDDLETOWN, R.I., June 30, 2020 (GLOBE NEWSWIRE) — KVH Industries, Inc., (Nasdaq: KVHI), announced today that the P-1775 inertial measurement […]
Himax Launches WiseEye WE-I Plus HX6537-A to Support AI Deep Learning with Google’s TensorFlow Lite for Microcontrollers
TAINAN, Taiwan, June 30, 2020 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and […]
Medallion Resources Completes $250,000 Private Placement
NOT FOR RELEASE IN THE UNITED STATESVANCOUVER, British Columbia, June 30, 2020 (GLOBE NEWSWIRE) — Medallion Resources Ltd. (TSX-V: MDL; […]
Guardion Health Sciences Completes Delivery of $875,000 Order to Malaysian Corporate Customer
Fulfills Initial Order of Astramern from Astramune Sdn Bhd, a Subsidiary of Ho Wah Genting BerhadSan Diego, California, June 30, […]
TLC Announces Completion of US$23 Million Financing
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, June 30, 2020 (GLOBE NEWSWIRE) — TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage […]
Nasdaq Adds The Global Earthquake Model (GEM) to its Risk Modelling Service
STOCKHOLM, Sweden and LONDON, June 30, 2020 (GLOBE NEWSWIRE) — Today Nasdaq (NDAQ) announced that The Global Earthquake Model (GEM), […]
Shell second quarter 2020 update note
The Hague, June 30, 2020 – This is an update to the second quarter 2020 outlook provided in the first […]
Liquidia to Host Conference Call to Provide Update on Recent Announcements
RESEARCH TRIANGLE PARK, N.C., June 29, 2020 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company […]
Liquidia Announces Pricing of Public Offering of Common Stock
RESEARCH TRIANGLE PARK, N.C., June 29, 2020 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company […]
